Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients

NCT02432833 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

428

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease

Interventions

DRUG: ENVARSUS®
DRUG: PROGRAF®
DRUG: ADVAGRAF®

Sponsor

Chiesi Farmaceutici S.p.A.